Effect of Mentha aquatica L. Extract on Bloating Symptom of Irritable Bowel Syndrome Disease: A Double-Blind Randomized, Placebo-Controlled Study
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that causes abdominal pain, distension, change of bowel habit, bloating, constipation, diarrhea, and mucus discharge along with stools. Although the disease causes long-term and agonizing pain, no ideal cure has been found for it so far. This study aimed to investigate the efficacy and compliance of Mentha aquatica L. extract for the treatment of bloating caused by IBS. This double-blind, randomized, placebo-controlled trial study was conducted in Tooba gastroenterology clinic in Sari, Iran, during 2019 (from January to May). A total of 104 patients with IBS in the age range of 20-80 years were randomly divided into two parallel groups of herbal medicine (MAC-330) and placebo. Study period consisted of a 4 weeks of administration, and 2 weeks of follow-up. IBS-associated symptoms including severity of bloating (as primary outcome) and frequency of defecation and abdominal pain were evaluated using a questionnaire before treatment, 1, 2 and 4 weeks after beginning treatment and 2 weeks after stopping treatment. There were no significant differences between the two groups in terms of their baseline characteristics (p > 0.05). The severity of bloating was significantly reduced in the both groups at fourth week (p < 0.030) and 2 weeks after stopping intervention (sixth week) (p < 0.026). The frequency of defecation has increased with the onset of the intervention until the fourth week of the treatment which was not significant. The abdominal pain reduced during the 4 weeks’ intervention, but it was not significant. Based on the obtained results, MAC-330 could not be used as an effective treatment for patients with IBS in short time; however, it reduces the abdominal bloating and pain in these patients, especially in the long-term use.
Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, et al. Bowel disorders. Gastroenterology 2016;15:1393-1407.e5.
Hungin A, Whorwell P, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther 2003;17:643-650.
Azpiroz F, Dapoigny M, Pace F, Müller-Lissner S, Coremans G, et al. Nongastrointestinal disorders in the irritable bowel syndrome. Digestion 2000;62:66-72.
Veale D, Kavanagh G, Fielding J, Fitzgerald O. Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenetic process. Rheumatology 1991;30:220-222.
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F. Functional bowel disorders. Gastroenterology 2006;130:1480-1491.
Soares RL. Irritable bowel syndrome: a clinical review. World J Gastroenterol 2014;20:12144.
Daly M, Zarate-Lopez N. Functional gastrointestinal disorders: history taking skills in practice. Clin Med 2021;21:2812-2819.
Cash BD, Schoenfeld P, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002;97:2812-2819.
Locke GR, Olden K, Peterson W, Quigley E, Schoenfeld P, et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002;97:S7-S26.
Rahimi R, Nikfar S, Rezaie A, Abdollahi M. Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis. World J Gastroenterol 2009;15:1548.
Darvish-Damavandi M, Nikfar S, Abdollahi M. A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome. World J Gastroenterol 2010;16:547.
Ford AC, Talley NJ, Spiegel BM, Foxx-Orenstein AE, Schiller L, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ 2008;337:a2313.
Mayer E, Berman S, Derbyshire S, Suyenobu B, Chang L, et al. The effect of the 5‐HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients. Aliment Pharmacol Ther 2002;16:1357-1366.
Prior A, Read N. Reduction of rectal sensitivity and post‐prandial motility by granisetron, a 5 HT3‐receptor antagonist, in patients with irritable bowel syndrome. Aliment Pharmacol Ther 1993;7:175-180.
Ford AC, Brandt LJ, Young C, Chey WD, Foxx-Orenstein AE, et al. Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis. AM J Gastroenterol 2009;104:1831-1843.
Rahimi R, Nikfar S, Abdollahi M. Selective serotonin reuptake inhibitors for the management of irritable bowel syndrome: a meta-analysis of randomized controlled trials. Arch Med Sci 2008;4:71.
Rezaie A, Nikfar S, Abdollahi M. The place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysis. Arch Med Sci 2010;6:49.
Ford AC, Quigley EM, Lacy BE, Lembo AJ, Saito YA, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol 2014;109:1547-1561.
Mozaffari S, Rahimi R, Abdollahi M. Implications of melatonin therapy in irritable bowel syndrome: a systematic review. Curr Pharm Des 2010;16:3646-3655.
Odes H, Madar Z. A double-blind trial of a celandin, aloevera and psyllium laxative preparation in adult patients with constipation. Digestion 1991;49:65-71.
Bundy R, Walker AF, Middleton RW, Marakis G, Booth JC. Artichoke leaf extract reduces symptoms of irritable bowel syndrome and improves quality of life in otherwise healthy volunteers suffering from concomitant dyspepsia: a subset analysis. J Altern Complement Med 2004;10:667-669.
Emendörfer F, Bellato F, Noldin VF, Cechinel-Filho V, Yunes RA, et al. Antispasmodic activity of fractions and cynaropicrin from Cynara scolymus on guinea-pig ileum. Biol Pharm Bull 2005;28:902-904.
Bundy R, Walker AF, Middleton RW, Booth J. Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: a pilot study. J Altern Complement Med 2004;10:1015-1018.
Saito YA, Rey E, Almazar-Elder AE, Harmsen SW, Zinsmeister AR, et al. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome. Am J Gastroenterol 2010;105:170-177.
Miquel J, Bernd A, Sempere J, Dıaz-Alperi J, Ramırez A. The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review. Arch Gerontol Geriatr 2002;34:37-46.
Cappello G, Spezzaferro M, Grossi L, Manzoli L, Marzio L. Peppermint oil (Mintoil®) in the treatment of irritable bowel syndrome: A prospective double blind placebo-controlled randomized trial. Dig liver Dis 2007;39:530-536.
Merat S, Khalili S, Mostajabi P, Ghorbani A, Ansari R, et al. The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome. Dig Dis Sci 2010;55:1385-1390.
Khanna R, MacDonald JK, Levesque BG. Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. J Clin Gastroenterol 2014;48:505-512.
Bijkerk C, Muris J, Knottnerus J, Hoes A, De Wit N. Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2004;19:245-251.
Vejdani R, Shalmani HRM, Mir-Fattahi M, Sajed-Nia F, Abdollahi M, et al. The efficacy of an herbal medicine, Carmint, on the relief of abdominal pain and bloating in patients with irritable bowel syndrome: a pilot study. Dig Dis Sci 2006;51:1501-1507.
Grzeszczuk M, Jadczak D. Estimation of biological value of some species of mint (Mentha L.). Herba polonica 2009;55:194-199.
Lawrence BM. Mint: the genus Mentha: CRC Press 2006.
Asadollah-Pour F, Jokar A, Nasiri E, Azadbakht M, Bari Z, et al. A comprehensive review on the ethnobotany, phytochemistry, pharmacology, and toxicology of Mentha aquatica L (water mint) as a wild shallow vegetable. Curr Pharm Des 2021;27:2615-2627.
Jellema P, Van Der Windt D, Schellevis F, Van der Horst H. Systematic review: accuracy of symptom‐based criteria for diagnosis of irritable bowel syndrome in primary care. Aliment pharmacol Ther 2009;30:695-706.
Meline T. Selecting studies for systemic review: Inclusion and exclusion criteria. Contemp Issues Commun Sci Disord 2006;33:21-27.
Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010;152:726-732.
Khonche A, Huseini HF, Mohtashami R, Nabati F, Kianbakht S. Efficacy of mentha pulegium extract in the treatment of functional dyspepsia: a randomized double-blind placebo-controlled clinical trial. J Ethnopharmacol 2017;206:267-273.
Matts JP, Lachin JM. Properties of permuted-block randomization in clinical trials. Control Clin Trials 1988;9:327-344.
Ariasepehr S, Ahmadzadeasl M. Basic Principles of Research Methodology in Medical Sciences. Nourdanesh. Tehran 2001; pp 84-92.
Association WM. World medical association declaration of helsinki. ethical principles for medical research involving human subjects. Bull World Health Organ 2001;79:373-374.
Dehghanian L, Rustee A, Hekmatdoost A. Effects of vitamin D3 supplementation on clinical symptoms in patients with irritable bowel syndrome and vitamin D deficiency: clinical trials. Iran J Nutr Sci Food Technol 2016;11:11-18.
Rahimian G, Babaeian M, Kheiri S, Moradi M, Rafieian-Kopaei M. Effect of Glycyrrhiza glabra (D-reglis tablet) on pain and defecation of patients with irritable bowel syndrome. Journal of Birjand University of Medical Sciences 2010;17:240-248.
Vahedi H, Meysamie A, Naderi A, Olfati G, GhaffariMarandi N, et al. The effect of amitriptyline in patients with pain and diarrhea predominant irritable Bowel Syndrome: a double-blind randomized controlled study. Govaresh 2006;11:139-144.
Ghadir MR, Habibinejad H, Heidari A, Vahedi H. Doxepin is more effective than nortriptyline and placebo for the treatment of diarrhea-predominant irritable bowel syndrome: a randomized triple-blind placebo-controlled trial. Tehran Univ Med J 2011;69:352-358.
Rostamkhani M, Khosravi S, Rezaie K, Forozan A, Rafiei F. The effect of ginger on the symptoms of irritable bowel syndrome: A randomized clinical trial. J Medicinal Plants 2018;17:112-121.
Fani A, Ghasedi M, Esmaeelion F, Alizadeh B. The effect of curcuma on improvement of clinical symptom of patients with irritable bowel syndrome. J Arak Uni Med Sci 2010;13:109-115.
May B, Köhler S, Schneider B. Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia. Aliment pharmacol Ther 2000;14:1671-1677.
Agah S, Shirali A, Sedigh N, Fereshtehnejad S, Saffarian H, et al. A comparative study of the effects of herbal therapy with carmint. Razi Journal of Medical Sciences 2008;15:27-38.
|Issue||Vol 6, No 4, 2021|
|Irritable bowel syndrome Bloating Mentha aquatica Herbal Extract|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|